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Background: A combination of increasing urbanization, behaviour change, and lack of health services in
slums put the urban poor specifically at risk of cardiovascular disease (CVD). This study aimed to evaluate
the impact of a community-based CVD prevention intervention on blood pressure (BP) and other CVD risk
factors in a slum setting in Nairobi, Kenya.
Design: Prospective intervention study includes awareness campaigns, household visits for screening, and
referral and treatment of people with hypertension. The primary outcome was overall change in mean systolic
blood pressure (SBP), while secondary outcomes were changes in awareness of hypertension and other
CVD risk factors. We evaluated the intervention’s impact through consecutive cross-sectional surveys at
baseline and after 18 months, comparing outcomes of intervention and control group, through a difference-
in-difference method.
Results: We screened 1,531 and 1,233 participants in the intervention and control sites. We observed a
significant reduction in mean SBP when comparing before and after measurements in both intervention
and control groups, 2.75 mmHg (95% CI 4.33 to 1.18, p0.001) and 1.67 mmHg (95% CI 3.17
to 0.17, p0.029), respectively. Among people with hypertension at baseline, SBP was reduced by 14.82
mmHg (95% CI 18.04 to 11.61, pB0.001) in the intervention and 14.05 (95% CI 17.71 to 10.38,
pB0.001) at the control site. However, comparing these two groups, we found no difference in changes in
mean SBP or hypertension prevalence.
Conclusions: We found significant declines in SBP over time in both intervention and control groups.
However, we found no additional effect of a community-based intervention involving awareness campaigns,
screening, referral, and treatment. Possible explanations include the beneficial effect of baseline measure-
ments in the control group on behaviour and related BP levels, and the limited success of treatment and
suboptimal adherence in the intervention group.
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Background
Cardiovascular disease (CVD) burden is rapidly rising
in sub-Saharan Africa (SSA), with the absolute number
of annual deaths increasing from 1.0 million in 2000 to
1.3 million in 2008 and expected to increase to approxi-
mately 2.1 million deaths annually by 2030 (1). CVD
deaths occur in African adults on average 10 or more
years earlier than among adults in Europe and North
America (2). Young adults in SSA who are in the prime of
their economically productive years are at a higher risk of
developing CVD and dying prematurely compared with
their western counterparts, posing a serious threat to the
economies of countries in SSA (3).
Hypertension is the main risk factor for CVD and has
recently become the leading risk factor for death in SSA
(4). Between 1990 and 2010, mean systolic blood pressure
(SBP) in Kenya rose from approximately 125 to around
130 mmHg (5). Over the same period in Europe and
North America, average blood pressure (BP) decreased
by approximately 3 mmHg (5). This is partly explained by
the fact that Kenya and other countries in SSA are in an
earlier phase of the epidemiological transition (6) from an
environment with predominantly nutritional deficiencies
and infectious diseases to one with degenerative diseases,
such as CVD related to industrialization, urbanization,
and changes in behaviour. Earlier studies in the Kenyan
context have shown how urban transition increases BP
among the population within a brief period of time (7),
which is possibly due to dietary changes, with increased
sodium, fat, and sugar, and decreased physical exercise.
In addition, urban transition and life in the slums are
linked to increased psychosocial stress, violence, and in-
security, which can lead to increased risk of CVD (8, 9).
Improving the availability of and access to appropriate
medication for people with hypertension is critical in
order to create a feasible and cost-effective way of slow-
ing down rising trends of CVD mortality in SSA, where
public health regulations and policies are weak (1012).
Countries in SSA are bearing a double burden of disease,
with the rise of non-communicable diseases occurring
against a backdrop of high prevalence of major commu-
nicable diseases such as HIV, tuberculosis, and malaria (13).
In this context, health care structures are overburdened,
specifically among the growing urban poor in SSA.
Currently, it is estimated that between 60 and 70% of
the urban population in SSA live in slums where reliable
health care facilities are virtually non-existent (14).
Kenyan slum dwellers are dependent on private health
care facilities that are unregulated and often run by
unqualified personnel who have very low understanding
and awareness of the rising burden of CVD. They there-
fore rarely measure BP and assess the presence of other
CVD risk factors (15), while medication for hypertension
is often not available. Access to private health facilities
in turn increases patients’ out-of-pocket expenditures,
since 90% of the slum population do not have health
insurance (16). The urban poor face a high prevalence of
hypertension but have low levels of awareness, access to
treatment, and BP control (17). Although policy docu-
ments have been developed addressing the CVD epidemic
in low-income settings (10), to our knowledge, there
have been no studies to evaluate their recommendations
in SSA (18). This study aims to evaluate the impact of a
community-based CVD prevention programme on BP
and other CVD risk factors in a slum setting in Nairobi,
Kenya.
Methods
Setting
The study was a prospective evaluation study of a
community-based intervention among the urban poor,
carried out in two slums called Korogocho and Viwandani.
They each had around 35,000 residents at the time of the
study. They are located about 5 to 10 km from the central
business district of Nairobi, Kenya, with 8 km between
them. High levels of poverty and unemployment, com-
bined with a lack of social amenities, including limited
access to quality primary health care and recreation
facilities, characterize these slums. Opportunities for
healthy lifestyle and medical support are few, increasing
CVD risk. The intervention took place in Korogocho,
with Viwandani designated as the control community.
The control population had access to CVD standard of
care, meaning that the only access to health care was
actually outside the slum.
Intervention
The multi-component intervention was designed based
on earlier studies on CVD risk factors conducted by the
African Population and Health Research Center (APHRC)
within the same setting (17, 19, 20), review of available
literature on effective community-based interventions for
CVD prevention (11), and input from various stake-
holders and experts from both the private sector and the
public health care delivery system (21). The intervention
has been described in more detail elsewhere (22). Briefly,
the four components of the intervention were as follows:
Paper context
Cardiovascular disease is reaching epidemic levels among the urban poor in SSA, with hypertension being the major risk
factor. This study is the first evaluation of an intervention to reduce cardiovascular risk in these settings, while focusing
on awareness, screening, treatment, and adherence of hypertension. The paper shows that reduction of blood pressure can
be reached in these settings; however, it is important to determine in future studies what the key drivers behind this are.
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1. Raising awareness prior to the door-to-door cam-
paign: Through radio jingles on the local radio
station Koch FM and awareness campaigns through
visits at churches, mosques, and other public spaces
within the slum to create understanding of CVD
and increase participation in the program.
2. Improving access to screening: Through door-to-
door household visits by community health workers
(CHWs) who measured BP and other anthropo-
metric outcomes and provided brief counselling on
cardiovascular risk factors to all consenting adults
aged 35 years and above. Because earlier research
revealed that unhealthy diets and reduced physical
exercise, aligned with the epidemiological transition
taking place in these settings, increase CVD risk; the
CHWs assessed study participants’ level of engage-
ment in risky lifestyle behaviour, including tobacco
use, alcohol use, physical activity levels, and dietary
habits. Consequently, they provided brief counsel-
ling assistance (BCA) on healthy lifestyle modifica-
tion using the six A’s approach Ask, Advice, Assist,
Arrange, Agree, and Affirm (23). Traditional BCA
does not include the sixth A (Affirm) as a separate
entity. However, due to the importance of lifestyle
change, CHWs encouraged study participants to
continue with any healthy lifestyle behaviour in
which they were currently engaged.
3. Facilitating access to treatment: Through distribu-
tion of vouchers for a free visit to the intervention
clinic to persons identified with hypertension; health
service improvements (nurses and clinical officers
were trained, primary care guidelines for hyperten-
sion management developed, and equipment sup-
plied); opening of a clinic at a central location in the
slum, within walking distance for the local popula-
tion, and also open on the weekends to increase
access to care for daily labourers who work during
weekdays; and incentives to CHWs to encourage
people identified with hypertension to come to the
clinic for an initial visit.
4. Promoting long-term retention in care: Through in-
centives to CHWs to encourage patients to visit the
clinic during the first 6 months, medication subsi-
dies, creation of patient support groups to build know-
ledge and understanding through train-the-trainer
sessions, and SMS reminders to improve adherence.
Evaluation
We evaluated the intervention’s impact through two cross-
sectional surveys conducted at baseline and after 18
months in the control and intervention communities.
The evaluation took place within the area covered by the
Nairobi Urban Health Demographic Surveillance System
(NUHDSS) that has been run by the APHRC since 2002
(24). As the NUHDSS was under close supervision during
the study period of 18 months, there were, to the best of
our knowledge, no other related interventions coinciding
with our study in both Korogocho and Viwandani.
The planned primary outcomes for this evaluation
were the difference in the change in the proportion of
the study population that were at moderate or high risk
of CVD (10% fatal and non-fatal) and the difference
in the change in mean SBP both at population level
and among people with hypertension at baseline. Due to
budgetary constraints and an ongoing feasibility study
(25), we decided during the study to abandon glu-
cose measurements and limit the primary outcome to
changes in SBP. Secondary outcomes included hyperten-
sion prevalence, change in mean diastolic blood pressure
(DBP), the proportion of respondents who were aware of
their hypertension, and the prevalence of other CVD risk
factors in both intervention and control groups.
Sample size and sampling
Participants in the surveys were adults aged 35 years or
older who were living in the Korogocho and Viwandani
slums and gave informed consent to participate in the
study. Exclusion criteria included pregnancy, a history
of CVD (myocardial infarction, stroke, heart failure,
or angina pectoris), psychiatric illness, and inability to
provide informed consent.
A total sample size of 3,220 respondents (1,610 per site)
was needed in order to detect a 5% reduction at endline in
the proportion of adults who are at moderate or high risk
of CVD in the intervention population versus no change
in the control population (assuming both populations
have similar a baseline prevalence of 25%) as a primary
outcome. The sample size took into account a 10% non-
response rate, a power of 90%, and an alpha of 0.05 (22).
The NUHDSS database, which contains the names,
locations, sex, and dates of birth of 15,000 individuals
aged 35 years and above in both slums, was used as a
sampling frame. Each individual in the NUHDSS has a
unique identification number (ID). Subsequently, a list of
random numbers was generated (26), and individuals
with IDs matching the random numbers were selected to
participate in the study.
Data collection
Demographic and socio-economic data were collected
during household visits by trained field interviewers.
Questionnaires included detailed questions on lifestyle
regarding CVD risk factors such as diet, physical activity,
and tobacco and alcohol uptake. In the intervention site
(Korogocho), trained CHWs collected the baseline study
data. After conducting each interview, they started
the counselling that was part of the intervention. In the
control site (Viwandani), field interviewers collected the
baseline study data. Field interviewers and CHWs were
trained together. Anthropometric measures, including
hip, waist, height, weight, and BP, were collected at study
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baseline in August 2012 and 18 months later in February
2014. BP was measured three times consecutively after
5 min of rest in the upper left arm with the arm positioned
at heart level against the chest, using validated Digital
Automatic Blood Pressure Monitors from OMRON†.
We took the average of the last two BP measurements for
analysis. Data quality was enforced by field supervisors
who conducted frequent and random sit-in and spot-
checks of interviews. These supervisors also performed
office editing of completed questionnaires to check for
completeness and consistency of collected data.
Analysis
We compared intervention and control participants’ char-
acteristics for both baseline and endline surveys using
t-test for continuous variables and chi-square test for
categorical variables. Changes in study outcomes were
assessed in two cohorts of participants: all adults aged 35
years and older participating in both baseline and endline
surveys, and those who were hypertensive at baseline and
participated in the endline survey. The differences were
evaluated using logistic and linear regression for binary
and continuous outcomes, respectively. The analysis was
adjusted for participant age, sex, education, and income.
Assuming parallel trends within the two communities of
Korogocho and Viwandani in the absence of any inter-
vention, difference-in-difference estimates were used to
assess the impact of the intervention on outcomes. An
interaction term between group (intervention/control)
and survey wave (baseline/endline) was included in each
model. All the analyses were performed using STATA
statistical software (26).
Results
Population characteristics
We screened 1,531 and 1,233 participants in the inter-
vention and control sites. During the baseline study,
refusal rates at the intervention and control sites were 2.4
and 7.5%, respectively. Due to high population mobility,
selected participants were difficult to find, so we had to
resample a second group and stopped recruiting once we
reached the target. The complete recruitment can be seen
in Fig. 1 following CONSORT guidelines. Specifically,
younger and male participants were more difficult to find
in both intervention and control sites. As the distribution
of our group was different from the expected distribution
based on the NUHDSS database, we weighted the results.
The prevalence of hypertension and mean SBP were
similar between the sites at baseline, but the DBP was
higher in the control group than in the intervention group
(81.4 mm Hg vs. 83.0 mm Hg, p0.001). The interven-
tion group was older, less educated, and poorer. It was
comprised of more females. It had less alcohol and
tobacco use but more physical activity compared with
the control group (Table 1).
Differences between both groups
Comparing the intervention and control group, we found
no significant difference in the mean SBP reduction at
population level (0.32 mmHg, 95% CI 2.48 to 1.83)
(Table 2). Likewise, no significant difference was detected
in the DBP reduction between intervention and control
(1.09 mmHg, 95% CI 0.29 to 2.46) (Table 2).
Among patients with hypertension at baseline, we
found no significant difference in SBP reduction between
Fig. 1. Overview of recruitment of the SCALE-Up study following CONSORT reporting.
Steven van de Vijver et al.
4
(page number not for citation purpose)
Citation: Glob Health Action 2016, 9: 30922 - http://dx.doi.org/10.3402/gha.v9.30922
intervention and control (0.32 mmHg, 95% CI 5.15
to 4.52) (Table 3). However, DBP decreased more in the
control hypertensive participants than among those in the
intervention group (3.31 mmHg, 95% CI 0.36 to 6.26,
p0.028) (Table 3).
We detected no difference between intervention and
control populations in the reduction of hypertension
prevalence (OR 1.13, 95% CI 0.84 to 1.52, p0.421) but
did find a significant improvement in the awareness of
being hypertensive in the intervention population com-
pared with the control population (OR 2.14, 95% CI 1.39
to 3.31, p0.001).
With respect to behavioural and physiological risk
factors, we found a significant decrease in the numbers
of those reporting inadequate physical activity among
the intervention group compared with the control group
at population level (OR 0.20, 95% CI 0.09 to 0.45,
pB0.001) and among the group with hypertension at
baseline (OR 0.10, 95% CI 0.02 to 0.50, p0.005).
Alcohol use (OR 1.62, 95% CI 1.13 to 2.30, p0.008)
and tobacco use (OR 1.60, 95% CI 1.20 to 2.15,
p0.002) increased significantly in the intervention
compared with the control group at population level.
Outcomes within both groups
We found a significant reduction in mean SBP between
baseline and endline measurements in both the interven-
tion and control groups: 2.75 mmHg (95% CI 1.18 to 4.33)
and 1.67 mmHg (95% CI 0.17 to 3.17), respectively (Table 2).
Table 1. The distribution of the study population interviewed in both baseline and endline surveys (intervention, n1,531;
control, n1,233)
Baseline Endline
Intervention Control Intervention Control 1
n % n % p-value0 n % n % p-value1
Proportion with SBP]140 mmHg and/or
DBP]90 mmHg
388 24.1 265 20.2 0.017 360 20.6 242 18.1 0.111
Mean systolic blood pressure 1,516 123.5 1,204 122.8 0.303 1,519 121.0 1,232 121.1 0.867
Mean diastolic blood pressure 1,516 81.4 1,204 83.0 0.001 1,519 80.8 1,232 81.9 0.009
Age
30 to 40 286 22.8 442 41.4 0.000 195 24.0 287 31.6 0.000
41 to 50 611 40.1 566 41.3 0.541 592 38.8 665 47.8 0.000
51 to 60 368 23.5 171 13.4 0.000 437 23.7 213 15.8 0.000
Above 60 266 13.6 54 3.9 0.000 307 13.5 68 4.8 0.000
Sex
Female 859 49.5 463 21.9 0.000 671 48.8 772 72.8 0.000
Male 672 50.5 770 78.1 0.000 860 51.2 461 27.2 0.000
Education
No education 278 15.6 51 3.3 0.000 244 12.9 42 2.9 0.000
Primary incomplete 332 20.6 127 9.7 0.000 451 27.4 111 8.2 0.000
Primary complete 685 46.8 622 48.9 0.278 621 43.7 631 49.9 0.002
Secondary 236 17.0 433 38.1 0.000 215 16.1 449 39.0 0.000
Income (Kshs.)
B5,000 798 62.0 219 17.1 0.000 685 55.8 162 12.3 0.000
5,0009,999 364 31.1 523 47.5 0.000 359 33.3 405 34.8 0.483
]10,000 77 6.9 333 35.4 0.000 117 11.0 549 53.0 0.000
Other risk factors
Tobacco use 159 11.6 192 19.2 0.000 187 14.2 149 13.8 0.793
Alcohol use 252 18.2 303 29.4 0.000 282 21.3 250 23.1 0.296
Insufficient fruit and vegetable consumption 1,073 70.5 878 71.3 0.660 1,114 73.1 966 79.1 0.001
Inadequate physical activity 75 4.2 27 1.7 0.000 75 4.3 97 7.3 0.001
Levels of awareness, treatment and control
% of those with high BP aware of it 156 9.0 81 5.0 0.000 321 18.5 90 6.2 0.000
% of those needing treatment on treatment 82 52.0 54 58.7 0.364 195 58.2 57 62.2 0.527
% of those on treatment with a controlled BP 24 28.4 18 36.4 0.359 99 53.4 20 35.6 0.026
P-value 0: comparing Intervention versus Control 1 at baseline.
P-value 1: comparing Intervention versus Control 1 at endline.
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Among those with hypertension at baseline in the
intervention (n388) and control (n266) settings, the
reduction of SBP pre versus post was larger: 14.82 mmHg
(95% CI 11.61 to 18.04) in the intervention and 14.05
(95% CI 10.38 to 17.71) at the control site. DBP
decreased by 7.55 mmHg (95% CI 5.57 to 9.54 mmHg)
in the intervention group and 10.67 mmHg (95% CI 8.44
to 12.89 mmHg) in the control group (Table 3).
In the control group, we also detected a decrease at
population level in smoking (OR 0.73, 95% CI 0.56 to
0.95) and alcohol use (OR 0.71, 95% CI 0.57 to 0.88).
Among patients with hypertension in the control group,
smoking (OR 0.51, 95% CI 0.28 to 0.90, p0.021) and
alcohol use (OR 0.62, 95% CI 0.38 to 0.99, p0.044) also
reduced significantly. Insufficient intake of fruits and
vegetables increased significantly at population level both
in intervention (OR 1.30, 95% CI 1.08 to 1.56, p0.006)
and control (OR 1.42, 95% CI 1.15 to 1.76, p0.001)
settings.
Discussion
In our study, we could not detect an effect attributable to
a multi-component intervention composed of awareness
campaigns, screening, and promotion of treatment and
Table 2. Differences at population level (intervention, n1,531; control, n1,233)
Estimate 95% CI p
SBP (coefficienta)
Difference between control and intervention areas at baseline 1.46 3.25 0.33 0.110
Difference between baseline and endline in intervention group 2.75 4.33 1.18 0.001
Difference between baseline and endline in control group 1.67 3.17 0.17 0.029
Difference-in-change between control and intervention 0.32 2.48 1.83 0.769
DBP (coefficienta)
Difference between control and intervention areas at baseline 2.68 3.82 1.54 0.000
Difference between baseline and endline in intervention group 0.55 1.54 0.44 0.278
Difference between baseline and endline in control group 1.40 2.37 0.43 0.005
Difference-in-change between control and intervention 1.09 0.29 2.46 0.121
Hypertension (odds ratiob)
Difference between control and intervention areas at baseline 0.84 0.67 1.07 0.159
Difference between baseline and endline in intervention group 0.83 0.68 1.02 0.072
Difference between baseline and endline in control group 0.75 0.59 0.94 0.014
Difference-in-change between control and intervention 1.13 0.84 1.52 0.421
Tobacco use (odds ratiob)
Difference between control and intervention areas at baseline 0.77 0.57 1.03 0.076
Difference between baseline and endline in intervention group 1.19 0.92 1.53 0.181
Difference between baseline and endline in control group 0.73 0.56 0.95 0.021
Difference-in-change between control and intervention 1.62 1.13 2.30 0.008
Alcohol use (odds ratiob)
Difference between control and intervention areas at baseline 0.84 0.66 1.08 0.168
Difference between baseline and endline in intervention group 1.15 0.94 1.42 0.183
Difference between baseline and endline in control group 0.71 0.57 0.88 0.002
Difference-in-change between control and intervention 1.60 1.20 2.15 0.002
Insufficient fruit and vegetable consumption (odds ratiob)
Difference between control and intervention areas at baseline 1.04 0.84 1.29 0.717
Difference between baseline and endline in intervention group 1.30 1.08 1.56 0.006
Difference between baseline and endline in control group 1.42 1.15 1.76 0.001
Difference-in-change between control and intervention 0.88 0.67 1.16 0.375
Inadequate physical activity (odds ratiob)
Difference between control and intervention areas at baseline 0.54 0.24 1.19 0.127
Difference between baseline and endline in intervention group 1.58 0.87 2.88 0.135
Difference between baseline and endline in control group 8.14 4.63 14.31 0.000
Difference-in-change between control and intervention 0.20 0.09 0.45 0.000
aCoefficient are estimates from linear regression and represent the difference in the average of an outcome.
bOdds ratio are estimates from logistic regression and represent the difference in the likelihood of an outcome.
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adherence in a slum setting compared with a control slum
population. However, a significant decrease in BP was
observed before and after the intervention period in the
intervention and control groups, both at population level
and among participants with hypertension at baseline.
Furthermore, we found changes in cardiovascular risk
factors with fruit and vegetable intake increasing in both
groups, while tobacco and alcohol use diminished in the
control group.
Differences between both groups
Although we detected a decrease of BP among the parti-
cipants in both groups, we found no additional significant
difference between the intervention and control groups.
Table 3. Differences among hypertensives at baseline (intervention, n388; control, n266)
Estimate 95% CI p
SBP (coefficienta)
Difference between control and intervention areas at baseline 1.66 1.94 5.26 0.366
Difference between baseline and endline in intervention group 14.82 18.04 11.61 0.000
Difference between baseline and endline in control group 14.05 17.71 10.38 0.000
Difference-in-change between control and intervention 0.32 5.15 4.52 0.898
DBP (coefficienta)
Difference between control and intervention areas at baseline 0.69 2.71 1.32 0.501
Difference between baseline and endline in intervention group 7.55 9.54 5.57 0.000
Difference between baseline and endline in control group 10.67 12.89 8.44 0.000
Difference-in-change between control and intervention 3.31 0.36 6.26 0.028
Awareness among hypertensives (odds ratiob)
Difference between control and intervention areas at baseline 0.94 0.64 1.36 0.730
Difference between baseline and endline in intervention group 2.14 1.67 2.75 0.000
Difference between baseline and endline in control group 1.05 0.72 1.52 0.817
Difference-in-change between control and intervention 2.14 1.39 3.31 0.001
Drug treatment for hypertension (odds ratiob)
Difference between control and intervention areas at baseline 0.59 0.21 1.67 0.323
Difference between baseline and endline in intervention group 0.81 0.42 1.56 0.529
Difference between baseline and endline in control group 0.64 0.20 2.03 0.452
Difference-in-change between control and intervention 1.84 0.57 5.94 0.306
Tobacco use (odds ratiob)
Difference between control and intervention areas at baseline 0.64 0.34 1.18 0.152
Difference between baseline and endline in intervention group 0.99 0.58 1.69 0.974
Difference between baseline and endline in control group 0.51 0.28 0.90 0.021
Difference-in-change between control and intervention 1.91 0.88 4.12 0.101
Alcohol use (odds ratiob)
Difference between control and intervention areas at baseline 0.66 0.39 1.13 0.132
Difference between baseline and endline in intervention group 0.94 0.59 1.48 0.778
Difference between baseline and endline in control group 0.62 0.38 0.99 0.044
Difference-in-change between control and intervention 1.39 0.73 2.64 0.309
Insufficient fruit and vegetable consumption (odds ratiob)
Difference between control and intervention areas at baseline 0.90 0.56 1.44 0.657
Difference between baseline and endline in intervention group 1.41 0.95 2.11 0.092
Difference between baseline and endline in control group 1.39 0.88 2.20 0.153
Difference-in-change between control and intervention 1.01 0.55 1.83 0.979
Inadequate physical activity (odds ratiob)
Difference between control and intervention areas at baseline 0.69 0.15 3.05 0.620
Difference between baseline and endline in intervention group 0.92 0.31 2.73 0.875
Difference between baseline and endline in control group 10.59 2.97 37.75 0.000
Difference-in-change between control and intervention 0.10 0.02 0.50 0.005
aCoefficient are estimates from linear regression and represent the difference in the average of an outcome.
bOdds ratio are estimates from logistic regression and represent the difference in the likelihood of an outcome.
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In all likelihood, we could not find an additional
intervention effect because the above-mentioned inter-
vention steps after the household screening were insuffi-
cient to yield an extra reduction in BP. Although we
succeeded in doubling the rates of awareness in the
intervention group from 10 to 21%, we were unable to
successfully refer a sufficiently large group of people
with hypertension to health care clinics and maintain
them on hypertension medication (25) to see a signifi-
cant effect compared with the control group. As described
in the process evaluation paper of the SCALE-UP
study (25), only a quarter of people diagnosed with
hypertension were retained in care, and of those, only a
third were able to achieve BP control. Therefore, among
people with hypertension, as in the overall population,
BP did not reduce significantly compared with the con-
trol group. Although participants in the intervention
group could visit the local clinic twice a week, including
the weekend, and get their medication for subsidized
prices, they still reported that lack of time and money
were the main reasons for them not showing up in the
clinic for regular treatment resulting in poor adherence.
It would be helpful to set up similar interventions where
costs and waiting time for patients could be reduced
through home-based management and medication for
free, for example.
It might be suggested that the similarity in decrease
of BP in the control group be caused by contamination
through spill-over effects in the intervention community
to the control community, despite the more than 8 km
distance between the two slums. We checked that radio
commercials run in Korogocho did not reach Viwandani,
and although the slum population is very mobile, we
have not come across study participants moving from
Korogocho to Viwandani. It still could be that the health
message from the campaigns has crossed the distance
through friends and family of participants and that people
at risk in the control study sought health care outside their
slum. However, the clinics with subsidized medication and
compliance programmes, stimulated through incentives
for CHW, were strictly limited to Korogocho.
Our initial decision to develop and implement an
integrated intervention focusing on awareness, access to
screening and treatment, and adherence was based on
earlier research showing that combination interventions
have beneficial effects (11). Although health promotion
was part of the intervention, as CHWs gave personal
lifestyle advice, we did not put much emphasis on this
as we thought it would be more feasible and cost-effective
to concentrate on the delivery of care and treatment.
However, health promotion might be more stimulated
taking into regard the potential effect of a one-off
screening and visit of a CHW in the control group. As
awareness of hypertension is still very low in slum settings
in Africa (6, 17, 27), a one-off measurement of BP and
questionnaire might already have an effect on BP. The
phenomenon of baseline measurements improving or
modifying outcomes of participants has been described
and has been seen in relation to BP (28, 29, Tanovic
et al., unpublished). As research in the slums is very scarce,
we were unable to locate studies specific to this setting.
Our results suggest that future interventions should
concentrate on several steps in order to create a more
sustainable reduction of cardiovascular risk. These would
include increasing awareness and adoption of healthy
lifestyles through screening and health promotion, ideally
leading people with a relevant cardiovascular risk profile
or hypertension to access the health care system, with
consequent increased treatment and adherence levels.
Outcomes within both groups
As BP levels are rising all over the continent (18), the
reduction in SBP at population level in both intervention
and control groups was substantial. The drop in SBP
was even larger among people with hypertension of more
than 14 mmHg. This is higher than other studies in SSA
describing successful BP reduction, for example, through
the introduction of health insurance to improve access to
quality care (30).
As the reduction of BP was similar in both groups,
it might be suggested that this was caused by an overall
natural trend. It is possible, however, that neither Korogocho
nor Viwandani had experienced any reduction in the pre-
valence of hypertension and related risk factors between
2008 and 2011 to support the idea of natural decrease
prior to our study (APHRC, unpublished data). On
the contrary, most studies in Africa have demonstrated
significant increases in BP and related risk factors over
relatively short time periods (18, 22).
A plausible explanation for the decrease in BP in both
groups could be the effect of the baseline measurements
of BP and questionnaires. Hypertensive participants in
the control group might have sought treatment when they
became aware of a high BP or adopted healthier lifestyles,
as is shown in their significant reduction of tobacco and
alcohol use, therefore improving their BP levels.
The increase in both groups of insufficient intake of
fruits and vegetables and inadequate physical activity is
in line with other studies in SSA (31) and is linked to
the rapid growth in the numbers of overweight and obese
people in these settings (32). However, the reduction in
alcohol and tobacco use seen in the control group during
the study period is contrary to expectations, given rising
consumption trends in other slums (33). As the field
workers and CHWs were trained together on CVD risk
factors, it might be that some field workers in the control
group, while conducting the interviews, provided some
health advice that might have influenced behaviour
regarding CVD risk factors in the control group.
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Strengths and limitations
The rapid growth of the urban poor in SSA and their
increased CVD risk are a growing concern. The strengths
of this study are that we were able to recruit a high
number of participants in this challenging setting and
that it is the first to describe outcomes of an intervention
to reduce cardiovascular risk in slum settings in SSA.
Limitations might include that initially we had in-
tended to measure blood glucose in order to determine
the overall CVD risk; however, budgetary constraints
and feasibility issues precluded this (25). As well, there
were challenges during implementation (34), for example,
to fully implement the support groups the way they
were envisioned. This might have negatively influenced
the results as the intended intervention was not fully
operationalized. In addition, we acknowledge the exis-
tence of secular trends such as food price fluctuations and
policy changes, which might have influenced our results,
but were beyond the scope of our study.
Conclusions
Although an effect attributable to a multi-component
intervention could not be detected, reductions in BP were
observed after the intervention period, in both interven-
tion and control groups, on the population level as well as
among participants with hypertension. Further research
is needed to explore CVD prevention strategies focusing
on screening and hypertension treatment adherence to
effectively confront the increasing burden of CVD among
Africa’s urban poor. Although we aimed in our paper for
a delivery of care model based on a literature review and
expert opinions, we suggest to include in future studies
the element of health promotion and population wide
approaches, taking into account the potential impact on
awareness and reduction of cardiovascular risk factors of
a one-off screening among the adult population in low
resource settings.
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